Skip to content
Disclosery

ANTIPODES PARTNERS Ltd: HCA position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of ANTIPODES PARTNERS Ltd on HCA, newest first. How the timeline and the estimate are built.

ANTIPODES PARTNERS Ltd held 289,941 HCA shares at 2026-06-30 per its 13F-HR filed 2026-08-06.

the latest 13F is the newest step

  1. period ended2026-06-30
    13F 289,941 shares
    Change vs previous 13F -1,511 shares

    2.07% of the 13F portfolio, value $113,045,096.

    13F-HR 0001652442-26-000005 filed by ANTIPODES PARTNERS Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2026-03-31
    13F 291,452 shares
    Change vs previous 13F -3,068 shares

    2.66% of the 13F portfolio, value $137,926,744.

    13F-HR 0001652442-26-000004 filed by ANTIPODES PARTNERS Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2025-12-31
    13F 294,520 shares
    Change vs previous 13F -67,659 shares

    2.89% of the 13F portfolio, value $137,509,917.

    13F-HR 0001652442-26-000002 filed by ANTIPODES PARTNERS Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2025-09-30
    13F 362,179 shares
    Change vs previous 13F -29,279 shares

    3.46% of the 13F portfolio, value $154,372,335.

    13F-HR 0001652442-25-000007 filed by ANTIPODES PARTNERS Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2025-06-30
    13F 391,458 shares
    Change vs previous 13F -43,965 shares

    4.65% of the 13F portfolio, value $149,979,002.

    13F-HR 0002005403-25-000004 filed by ANTIPODES PARTNERS Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2025-03-31
    13F 435,423 shares
    Change vs previous 13F +406,682 shares

    4.71% of the 13F portfolio, value $150,472,490.

    13F-HR 0001652442-25-000003 filed by ANTIPODES PARTNERS Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  7. period ended2024-12-31
    13F 28,741 shares
    Change vs previous 13F not available

    0.3% of the 13F portfolio, value $8,627,308.

    13F-HR 0001652442-25-000002 filed by ANTIPODES PARTNERS Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).